Experimental and clinical aspects of the carcinogenic potential of steroid contraceptives.
D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D002273:Carcinogens; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004717:Endometrium; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009369:Neoplasms / Q000139:chemically induced* / Q000453:epidemiology; D009374:Neoplasms, Experimental / Q000139:chemically induced*; D011372:Progestins / Q000009:adverse effects; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014594:Uterine Neoplasms / Q000139:chemically induced
D002273:Carcinogens; D003276:Contraceptives, Oral; D004967:Estrogens; D011372:Progestins